home · filing · 0001641172-25-008281
8-K
filed May 2, 2025, 7:59 PM ET
ticker FATAQ
CIK 0001705012
leadership
confidence high
sentiment neutral
materiality 0.60
FAT Brands appoints Taylor Wiederhorn as Co-CEO; Rob Rosen transitions to consultant
Fat Brands, Inc
Rob Rosen stepped down as Co-CEO effective April 29, 2025; will serve as consultant at $45,833/month.
Taylor Wiederhorn, former Chief Development Officer, appointed Co-CEO alongside Ken Kuick.
Wiederhorn, age 36, has been a director since March 2023 and with FAT Brands since October 2017.
Rosen will continue vesting in equity grants under the 2017 Omnibus Plan during consulting role.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2025-04-29
Successor Taylor Wiederhorn
Filed May 2, 2025, 7:59 PM ET
Effective April 29, 2025, Robert Rosen stepped down from his position as Co-Chief Executive Officer of FAT Brands Inc. (the “ Company ”)
Effective 2025-04-29
Filed May 2, 2025, 7:59 PM ET
and Taylor Wiederhorn was appointed Co-Chief Executive Officer of the Company.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Robert Rosen departed as Co-Chief Executive Officer at Fat Brands, Inc.
Action stepped down
Role Co-Chief Executive Officer
Exact text from the filing
Effective April 29, 2025, Robert Rosen stepped down from his position as Co-Chief Executive Officer of FAT Brands Inc. (the “ Company ”)
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Taylor Wiederhorn was appointed as Co-Chief Executive Officer at Fat Brands, Inc.
Action appointed
Role Co-Chief Executive Officer
Exact text from the filing
and Taylor Wiederhorn was appointed Co-Chief Executive Officer of the Company.
View on SEC.gov
Source: SEC EDGAR
accession 0001641172-25-008281
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.